|
The AAV-GAD bridging study met the primary endpoint of safety and tolerability, and showed early promise in Parkinson’s patients.
|
 |
|
The MHRA shared the latest updates following its consultation period on the new regulation during a webinar on 15 October.
|
|
|
The integration of ICTS into Eximia's network is expected to enhance clinical trial access for the West Des Moines community.
|
|
|
After a two-year delay, J&J is ready to disrupt Intuitive’s market domination with Da Vinci.
|
|
|
The ageing global population will lead to an increase in acute kidney injury and a growing need for more therapeutic options.
|
|
|
More than six MASH candidates are currently in Phase III trials.
|
|
|
The company will report topline results from the trial in the first quarter of 2025.
|
|
